|
|
Maria Febbraio, Eugene A. Podrez, Jonathan D. Smith, David P. Hajjar, Stanley L. Hazen, Henry F. Hoff, Kavita Sharma, Roy L. Silverstein
J Clin Invest. 2000;
105(8):1049
doi:10.1172/JCI9259
Abstract |
Full text
| PDF

M
acrophage scavenger receptors have been implicated as key players in the pathogenesis of atherosclerosis. To assess the role of the class B scavenger receptor CD36 in atherogenesis, we crossed a CD36-null strain with the atherogenic apo E–null strain and quantified lesion development. There was a 76.5% decrease in aortic tree lesion area (Western diet) and a 45% decrease in aortic sinus lesion area (normal chow) in the CD36-apo E double-null mice when compared with controls, despite alterations in lipoprotein profiles that often correlate with increased atherogenicity. Macrophages derived from CD36-apo E double-null mice bound and internalized more than 60% less copper-oxidized LDL and LDL modified by monocyte-generated reactive nitrogen species. A similar inhibition of in vitro lipid accumulation and foam cell formation after exposure to these ligands was seen. These results support a major role for CD36 in atherosclerotic lesion development in vivo and suggest that blockade of CD36 can be protective even in more extreme proatherogenic circumstances.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(215)
| Title and authors |
Publication |
Year |
Teaching an old dog new tricks: potential antiatherothrombotic use for statins
Roy L. Silverstein
|
J. Clin. Invest.
|
2012 |
Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis
Tanu Goyal, Sona Mitra, Magomed Khaidakov, Xianwei Wang, Sandeep Singla, Zufeng Ding, Shijie Liu, Jawahar L. Mehta
|
Curr Atheroscler Rep
|
2012 |
Patients with CD36 Deficiency Are Associated with Enhanced Atherosclerotic Cardiovascular Diseases
Miyako Yuasa-Kawase, Daisaku Masuda, Taiji Yamashita, Ryota Kawase, Hajime Nakaoka, Miwako Inagaki, Kazuhiro Nakatani, Kazumi Tsubakio-Yamamoto, Tohru Ohama, Akifumi Matsuyama
|
JAT
|
2012 |
Endovascular aneurysm repair reverses the increased titer and the inflammatory activity of interleukin-1α in the serum of patients with abdominal aortic aneurysm
Clara M. Yates, Mohamed Abdelhamid, Donald J. Adam, Gerard B. Nash, Andrew W. Bradbury, G. Ed Rainger
|
Journal of Vascular Surgery
|
2011 |
Diet and Atherosclerosis in Apolipoprotein E-Deficient Mice
Katsumi IMAIZUMI
|
Biosci. Biotechnol. Biochem.
|
2011 |
Citrus flavonoid 5-demethylnobiletin suppresses scavenger receptor expression in THP-1 cells and alters lipid homeostasis in HepG2 liver cells
Jui-Hung Yen, Ching-Yi Weng, Shiming Li, Ya-Hsuan Lo, Min-Hsiung Pan, Shih-Hang Fu, Chi-Tang Ho, Ming-Jiuan Wu
|
Mol. Nutr. Food Res.
|
2011 |
NLRP3 inflammasomes link inflammation and metabolic disease
Dominic De Nardo, Eicke Latz
|
Trends in Immunology
|
2011 |
Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway
B. Ren, J. Hale, S. Srikanthan, R. L. Silverstein
|
Blood
|
2011 |
Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms
A. Ghosh, G. Murugesan, K. Chen, L. Zhang, Q. Wang, M. Febbraio, R. M. Anselmo, K. Marchant, J. Barnard, R. L. Silverstein
|
Blood
|
2011 |
Pathogenic Role of Scavenger Receptor CD36 in the Metabolic Syndrome and Diabetes
David J. Kennedy, Sangeeta R. Kashyap
|
Metabolic Syndrome and Related Disorders
|
2011 |
|